Research Article

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration

Table 3

Predictors of retinopathy and neuropathy multivariate models.

ParameterRetinopathyNeuropathy
OR (95% CI) scoreOR (95% CI) score

Duration of diabetes (per 5 years)1.48 (1.41–1.56)14.641.31 (1.25–1.37)11.52
Insulin use2.77 (2.23–3.46)9.132.19 (1.86–2.58)9.36
Weight (per 5 kg)1.09 (1.07–1.11)8.83
Previous PCI0.75 (0.61–0.91)2.940.60 (0.51–0.70)6.32
Total cholesterol (per 10 mg/dl)1.05 (1.04–1.07)6.23
History of PAD1.88 (1.45–2.43)4.82
History of HF1.65 (1.35–2.02)4.821.32 (1.12–1.56)3.23
Previous stroke2.06 (1.51–2.82)4.541.86 (1.42–2.45)4.45
Diastolic blood pressure (per 10 mmHg)0.88 (0.82–0.95)3.25
Sulphonylurea use1.29 (1.11–1.51)3.24
Previous CABG0.72 (0.52–0.98)2.110.66 (0.51–0.86)3.06
Presence of hypertension1.46 (1.11–1.91)2.691.39 (1.12–1.72)3.00
Body mass index (per 5 kg/m2)1.12 (1.04–1.22)2.99
Glucose (per 10 mg/dl)1.02 (1.0-1.04)2.291.02 (1.01–1.03)2.87
eGFR (per 10 ml/min/1.73m2)0.94 (0.90–0.98)2.66
Male sex1.25 (1.06–1.47)2.60
HDL cholesterol (per 10 mg/dl)1.11 (1.02–1.20)2.53
Age (per 5 years)1.05 (1.01–1.10)2.20
HbA1c (per 1%)1.09 (1.00–1.19)1.98

Model AUC = 0.81 (retinopathy) and model AUC = 0.76 (neuropathy). HF: heart failure; PCI: percutaneous coronary intervention; eGFR: estimated glomerular filtration rate; HDL: high-density lipoprotein; CABG: coronary artery bypass grafting; HbA1c: glycated hemoglobin; PAD: peripheral artery disease.